Compare ATOM & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOM | QTRX |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.7M | 160.0M |
| IPO Year | 2016 | 2017 |
| Metric | ATOM | QTRX |
|---|---|---|
| Price | $2.98 | $2.84 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.17 |
| AVG Volume (30 Days) | ★ 515.6K | 503.8K |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.41 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $62,000.00 | ★ $37,632,000.00 |
| Revenue This Year | $361.54 | $3.21 |
| Revenue Next Year | $233.33 | $9.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $1.89 | $2.15 |
| 52 Week High | $12.37 | $8.77 |
| Indicator | ATOM | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 24.28 | 41.99 |
| Support Level | $2.25 | $2.34 |
| Resistance Level | $3.51 | $3.99 |
| Average True Range (ATR) | 0.23 | 0.23 |
| MACD | -0.09 | -0.06 |
| Stochastic Oscillator | 4.09 | 13.03 |
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.